Status

[¹⁶⁹Er]Erbium-citrate 186Re]Rhenium-sulphide [90Y]Yttrium-citrate are approved in a few European countries for the treatment of a range of refractory painful arthropathies. National rules concerning the different approvals of all radionuclides used for radiosynoviorthesis must be strictly considered.